Mayo Clinic Phage Program Biobank
NCT05314426 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-06-12
Summary
The purpose of this study is to help scientists and clinicians discover answers to research questions related to antibiotic-resistant bacterial infections, and the role that phage therapy plays as a possible treatment.
Conditions
- Bacteriophage Therapy
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Gina Suh, MD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-19
- Primary Completion
- 2027-04-30
- Completion
- 2027-04-30
Countries
- United States
Study Locations
More Related Trials
-
Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia
NCT04636554 ·Status: NO_LONGER_AVAILABLE
-
MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial
NCT00814151 ·Status: COMPLETED
-
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
NCT05177107 ·Status: TERMINATED ·Phase: PHASE2
-
T2Resistance - Detection of Resistance Related Genes
NCT05231187 ·Status: COMPLETED
-
Bacteriophage Therapy of Difficult-to-treat Infections
NCT05498363 ·Status: COMPLETED
-
Phage Therapy for the Prevention and Treatment of Pressure Ulcers.
NCT04815798 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Bacteriophage Therapy for Difficult-to-treat Infections: the Implementation of a Multidisciplinary Phage Task Force
NCT06368388 ·Status: RECRUITING
-
Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients
NCT02116010 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
B-PaLMZ for TB Meningitis
NCT07227779 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS
NCT00754273 ·Status: COMPLETED
-
Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
NCT00084266 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA
NCT01640886 ·Status: TERMINATED
-
Studying the Distribution of Accessory Gene Regulator (Agr) Quorum Sensing System and the Prevalence of Linezolid and Mupirocin Resistance in Biofilm Producer/Non Producer Staphylococcus Aureus in Sohag University Hospitals
NCT06291181 ·Status: COMPLETED ·Phase: NA
-
MDR Bacilli Surveillance and Clinical Feature in China
NCT02140853 ·Status: UNKNOWN
-
Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection
NCT07228702 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Phage Therapy for the Treatment of Urinary Tract Infection
NCT05537519 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis
NCT05329168 ·Status: WITHDRAWN ·Phase: PHASE2
-
Virulence Determinants in S Aureus Bacteremia
NCT00319826 ·Status: COMPLETED
-
Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine
NCT01311817 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Evaluation of the Residual Antimicrobial Activity
NCT04495920 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections
NCT01198262 ·Status: COMPLETED
-
Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
NCT05383742 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples
NCT06531031 ·Status: NOT_YET_RECRUITING
-
Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
NCT07110636 ·Status: RECRUITING ·Phase: NA
-
AMR-DetecTool for the Diagnostic of MDR Bacterial Infections
NCT05378217 ·Status: COMPLETED